Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rana

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Immunity|June 17, 2018
Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid CellsTimotheus Y F Halim, Batika M J Rana, Jennifer A Walker, et al.
Mucosal Immunology|May 28, 2020
Group-2 innate lymphoid cell-dependent regulation of tissue neutrophil migration by alternatively activated macrophage-secreted Ear11Veera Panova, Mayuri Gogoi, Noe Rodriguez-Rodriguez, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations <i>In Vivo</i>: A Clinical TrialJaideep Dhariwal, Aoife Cameron, Ernie Wong, et al.
Science Advances|April 18, 2025
Molecular basis of pyruvate transport and inhibition of the human mitochondrial pyruvate carrierMaximilian Sichrovsky, Denis Lacabanne, Jonathan J Ruprecht, et al.
The Journal of Experimental Medicine|June 29, 2019
A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissueBatika M J Rana, Eric Jou, Jillian L Barlow, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2014
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivoDavid J Jackson, Heidi Makrinioti, Batika M J Rana, et al.
Science (New York, N.Y.)|October 18, 2017
A radio counterpart to a neutron star mergerG Hallinan, A Corsi, K P Mooley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is IneffectiveCharles P Hannon, Susan M Goodman, Matthew S Austin, et al.
The Journal of Arthroplasty|October 1, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is IneffectiveCharles P Hannon, Susan M Goodman, Matthew S Austin, et al.
Arthritis Care & Research|September 25, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is IneffectiveCharles P Hannon, Susan M Goodman, Matthew S Austin, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Immunity|June 17, 2018
Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid CellsTimotheus Y F Halim, Batika M J Rana, Jennifer A Walker, et al.
Mucosal Immunology|May 28, 2020
Group-2 innate lymphoid cell-dependent regulation of tissue neutrophil migration by alternatively activated macrophage-secreted Ear11Veera Panova, Mayuri Gogoi, Noe Rodriguez-Rodriguez, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations <i>In Vivo</i>: A Clinical TrialJaideep Dhariwal, Aoife Cameron, Ernie Wong, et al.
Science Advances|April 18, 2025
Molecular basis of pyruvate transport and inhibition of the human mitochondrial pyruvate carrierMaximilian Sichrovsky, Denis Lacabanne, Jonathan J Ruprecht, et al.
The Journal of Experimental Medicine|June 29, 2019
A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissueBatika M J Rana, Eric Jou, Jillian L Barlow, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2014
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivoDavid J Jackson, Heidi Makrinioti, Batika M J Rana, et al.
Science (New York, N.Y.)|October 18, 2017
A radio counterpart to a neutron star mergerG Hallinan, A Corsi, K P Mooley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is IneffectiveCharles P Hannon, Susan M Goodman, Matthew S Austin, et al.
The Journal of Arthroplasty|October 1, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is IneffectiveCharles P Hannon, Susan M Goodman, Matthew S Austin, et al.
Arthritis Care & Research|September 25, 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is IneffectiveCharles P Hannon, Susan M Goodman, Matthew S Austin, et al.
Pageof 9